• Home
  • Getting Started
    • ChartMill OverviewGrowth TradersTechnical Swing Traders Long Term Investors
  • Tools
    • Stock ScreenerStock ChartsFull Screen Stock ChartsMarket MonitorSectorsEarningsAnalyzerInsider TradingUp- and Downgrades
  • Stock Market
    • Top Gainers and LosersNew 52 Week High and LowGap Up and Gap DownMost ActivePremarket MoversAfter-Hours MoversEarnings CalendarAll US stocksAll Canadian stocksAll European stocks
  • Trading Ideas
  • News
  • Blog
  • Documentation
    • Documentation CenterVideosIndicatorsPropertiesScreener Market data
  • Popular Articles
    • Bull FlagsRelative StrengthPocket PivotsSupport and ResistanceRSI IndicatorMACD IndicatorPiotroski F-scoreSqueeze PlaysWeinsteinTechnical Breakout SetupsTrading TipsPremarket MoversGap Up StocksBest Dividend StocksBullish Engulfing PatternAscending Triangle PatternSwing TradingAll articles ...
  • Subscriptions
  • Account
  • Disclaimer
AffiliatePrivacy
Logo image of SBBP

Strongbridge Bio Ord (SBBP) Stock News

NASDAQ:SBBP - Nasdaq -

2  +0.03 (+1.52%)

After market: 2.02 +0.02 (+1%)

Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News

SBBP Latest News, Press Relases and Analysis

All
Press Releases
4 years ago - By: Strongbridge Biopharma plc
News Image

Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.

4 years ago - By: Benzinga - Mentions: MOR ZNTL ESPR ATNX ...
News Image

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs

4 years ago - By: Benzinga - Mentions: RMTI SNGX CMRX JAGX ...
News Image

12 Health Care Stocks Moving In Tuesday's After-Market Session

4 years ago - By: Zacks Investment Research
News Image

Strongbridge Biopharma (SBBP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release